Cite
HARVARD Citation
Schueller, O. et al. (2022). Absolute Bioavailability, Mass Balance, and Metabolic Profiling Assessment of [14C]‐Belumosudil in Healthy Men: A Phase 1, Open‐Label, 2‐Part Study. Clinical pharmacology in drug development. 11 (7), pp. 786-794. [Online].